Founded in Berlin, Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG is an independent pharmaceutical company with a strong focus on the research, development, and distribution of specialized medicines, particularly antidotes for toxic metal exposure and radionuclides. The company also offers treatments for conditions such as Wilson's disease, vitamin deficiencies, rheumatoid arthritis, and toxoplasmosis. With decades of expertise, Heyl plays a crucial role in regulatory affairs and pharmaceutical marketing on a global scale.
CEO
Goerzallee 253, 14167 Berliin, Saksamaa
+49 30 816960